Table 1. Baseline characteristics of the study population.
AST: aspartate aminotransferase; ALT: alanine aminotransferase; APRI: aspartate transaminase-to-platelet ratio index; FIB-4: fibrosis-4
| Characteristics | Total Patients (n = 520) |
| Females | 136 (26.2%) |
| Males | 384 (73.8%) |
| Age (Mean ± SD) in years | 36.36±14.39 |
| BMI (kg/m2) | 21.16±3.78 |
| Haemoglobin (gm/dl) | 12.58±2.25 |
| Bilirubin (mg/dL) | 1.22±0.84 |
| AST (IU/L) | 59.22±45.71 |
| ALT (IU/L) | 63.96±53.89 |
| ALP (IU/L) | 256.07±119.02 |
| Platelets (/mm3) | 156946.73±65526.20 |
| Albumin (gm/dl) | 3.91±0.79 |
| FibroScan Score (kPa) | 12.76±13.80 |
| Stages of liver fibrosis as per FibroScan, n (%) | |
| F0-F1 (<7 kPa) | 248 (47.7%) |
| F2 (7-8.99 kPa) | 100 (19.2%) |
| F3 (9-12.49 kPa) | 42 (8.1%) |
| F4 (≥12.5 kPa) | 130 (25.0%) |
| APRI score (Median) | 0.67 (0.13-31.43) |
| FIB-4 score (Median) | 1.36 (0.13-35.30) |
| FibroScan (Median) | 7.20 (2.30-75.00) |